Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases

• Published in: Nutrients Vol. 13; no. 8; p. 2830
• Main Authors: Guerra, João V. S, Dias, Marieli M. G, Brilhante, Anna J. V. C, Terra, Maiara F, García-Arévalo, Marta, Figueira, Ana Carolina M
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-08-2021; MDPI
• Subjects: Activity patterns; Cardiovascular diseases; China; Contamination; Coronaviruses; COVID-19; Development and progression; diabetes; Diabetes mellitus; Diseases; Exercise; Fatty liver; Liver diseases; MAFLD; Metabolism; Molecular modelling; Mortality; NCDs; Obesity; Pathophysiology; Physical activity; Physiological aspects; Review; Risk analysis; Risk factors; Severe acute respiratory syndrome coronavirus 2; Signs and symptoms; Type 2 diabetes; Viruses; China
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu13082830

Throughout the 20th and 21st centuries, the incidence of non-communicable diseases (NCDs), also known as chronic diseases, has been increasing worldwide. Changes in dietary and physical activity patterns, along with genetic conditions, are the main factors that modulate the metabolism of individuals, leading to the development of NCDs. Obesity, diabetes, metabolic associated fatty liver disease (MAFLD), and cardiovascular diseases (CVDs) are classified in this group of chronic diseases. Therefore, understanding the underlying molecular mechanisms of these diseases leads us to develop more accurate and effective treatments to reduce or mitigate their prevalence in the population. Given the global relevance of NCDs and ongoing research progress, this article reviews the current understanding about NCDs and their related risk factors, with a focus on obesity, diabetes, MAFLD, and CVDs, summarizing the knowledge about their pathophysiology and highlighting the currently available and emerging therapeutic strategies, especially pharmacological interventions. All of these diseases play an important role in the contamination by the SARS-CoV-2 virus, as well as in the progression and severity of the symptoms of the coronavirus disease 2019 (COVID-19). Therefore, we briefly explore the relationship between NCDs and COVID-19.